Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation.
Autorzy:
Parry MG; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK. .; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England. . Cowling TE; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK. Sujenthiran A; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England. Nossiter J; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England. Berry B; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England. Cathcart P; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Aggarwal A; Department of Cancer Epidemiology, Population, and Global Health, King's College London, London, UK.; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, UK. Payne H; Department of Oncology, University College London Hospitals, London, UK. van der Meulen J; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK. Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Department of Urology, Salford Royal NHS Foundation Trust, Salford, UK. Gnanapragasam VJ; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Cambridge Urology Translational Research and Clinical Trials Office, Cambridge Biomedical Campus, Cambridge, UK.
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2020 May 28; Vol. 18 (1), pp. 114. Date of Electronic Publication: 2020 May 28.
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study.
Autorzy:
Gnanapragasam VJ; Academic Urology Group, Department of Surgery and Oncology, University of Cambridge, Box 279 (S4), Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. .; Addenbrookes Hospital, Department of Urology, Addenbrooke's Hospital, Cambridge, UK. . Bratt O; Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden. Muir K; Institute of Population Health, University of Manchester, Manchester, UK. Lee LS; Department of Urology, Singapore General Hospital, Singapore, Singapore. Huang HH; Department of Urology, Singapore General Hospital, Singapore, Singapore. Stattin P; Department of Surgical and Perioperative Science, Urology and Andrology, Umeå University, Umeå, Sweden.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Lophatananon A; Institute of Population Health, University of Manchester, Manchester, UK.
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2018 Feb 28; Vol. 16 (1), pp. 31. Date of Electronic Publication: 2018 Feb 28.
Novel three-dimensional bone 'mapping' software can help assess progression of osseous metastases from routine CT.
Autorzy:
Thurtle D; Academic Urology Group, Department of Surgery, University of Cambridge, Box 279, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. .; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. . Treece GM; Medical Imaging Group, Department of Engineering, University of Cambridge, Trumpington Street, Cambridge, CB2 1PZ, UK. Barrett T; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.; Department of Radiology, University of Cambridge School of Clinical Medicine, Hills Road, Cambridge, CB2 0QQ, UK. Gnanapragasam VJ; Academic Urology Group, Department of Surgery, University of Cambridge, Box 279, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
